Cardiol Therapeutics Bolsa (NASDAQ: CRDL)

Últimas noticias sobre Cardiol Therapeutics (NASDAQ:CRDL) Bolsa

Cardiol Therapeutics

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

Cardiol Therapeutics Inc. - Class A Common Shares

Cardiol Therapeutics Inc

FuelCell Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCEL#NASDAQ">FCEL</a>) and Malaysia Marine and Heavy Engineering Sdn Bhd (MMHE), a wholly owned subsidiary of Malaysia Marine and Heavy Engineering Holdings Berhad (KLSE: MHB), have announced the signing of a Joint Development Agreement (JDA) to co-develop large-scale hydrogen production systems and technologies across Asia, New Zealand, and Australia.
Building on a memorandum of understanding signed in February 2023, the JDA represents a pivotal step for the two companies, driven by a shared vision to make clean hydrogen production easily accessible and viable. The collaboration underscores FuelCell Energy and MHB's commitment to advancing green energy solutions and supporting global decarbonization and energy transition goals.
Under the terms of the JDA, the two companies will bring together FuelCell Energy's cutting-edge solid oxide electrolyzer (SOEC) technology and MHB's expertise in large-scale fabrication to develop modular solutions that support rapid deployment of commercial hydrogen production.
&nbsp;
Project Award: Detailed Feasibility Study (DFS) in Malaysia
In conjunction with the JDA, FuelCell Energy and MHB are collaborating to support a contract awarded to FuelCell Energy for a Detailed Feasibility Study (DFS) of a low-carbon fuel production facility in Malaysia. The DFS will evaluate the production of low-carbon fuel utilizing SOEC technology with carbon dioxide and water as feedstocks.
Additionally, as part of the DFS, the companies will collaborate with KBR LLC, which will provide its proprietary low-carbon fuel synthesis technology.
The project aligns with Malaysia's goals to achieve net-zero carbon emissions by 2050, while advancing its national hydrogen value chain.

Government

News

Regulations

FCEL

FuelCell Energy and MMHE Partner to Expand Large-Scale Hydrogen Production Across Asia and Australia

<a href="https://www.globenewswire.com/Tracker?data=Dpe5uBgPoRsuPOQGNwzt4IJT8XrmnvAhEssnuY-JhnmjOqVNg5B_2V5q6UvyAibulWUWNNzAel2mN0rHqhDuf2fXQH5XE_U9Ip7xRBSiIJXrWHbwT4w36NknfmZNGyHvwZOXeOOkooujjKGCo7RmbdGzPhWqs6Z3r90s46OfUSWwZuvusTfI2_r1ngsCYd0DcOzdzRQTr8QC1RBQB3kj2A==">Lantronix Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LTRX#NASDAQ">LTRX</a>), a global leader of compute and connectivity for IoT solutions enabling Edge Intelligence, today announced that it will demonstrate its <a href="https://www.globenewswire.com/Tracker?data=qeH--YO6r-k5_EVN380NHF0E5AB0mzXlq7_2JguTbH2G9CCDuzbp5kfZ23_KKM1UDFHDhhVHuR-TB_l6KcWXB6qIDb0XFzxwttSUUiu7pQkm9Nyt_OCOV4suehN8ZKvurjC4ddEF80ur8n2IHtPdN-eRqn2futGUAXNLFMNB3-iCgk7O7b3dkldbX117gl41RQCreJ82ZmC-wVQSZUetTw==">SmartLV,</a> the first AI-enabled IoT Edge Compute Cellular Gateway, in the Qualcomm&#xAE; Technologies Booth at Hall 5/5-161 at Embedded World, March 11–13, 2025, in Nuremberg, Germany. Powered by the Qualcomm Dragonwing&#x2122; IQ-615, this groundbreaking innovation is designed specifically for low-voltage substations and distribution automation applications in next-generation smart grids, utilities and industrial sectors.
The Lantronix SmartLV demonstration in Qualcomm Technologies' booth at Embedded World will highlight the cutting-edge Edge AI capabilities of this next-generation IoT cellular gateway, which utilizes the Dragonwing IQ-615. The SmartLV demo will showcase real-world use cases, including real-time monitoring of power consumption for a low-voltage grid. Combining this data with real-world pricing information enables grid operators to steer power and users to cost-optimize their consumption.

LTRX

Lantronix To Unveil AI-Powered SmartLV IoT Gateway for Smart Grids at Embedded World 2025

AlTi Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALTI#NASDAQ">ALTI</a>) ("AlTi" or "AlTi Tiedemann Global"), a leading independent global wealth manager with over $77 billion in combined assets, announces the acquisition of Kontora Family Office GmbH ("Kontora"). Kontora is a multi-family office and asset management company headquartered in Hamburg, Germany focused on UHNW families, entrepreneurs and select institutions. The firm has assets under management ("AUM") of approximately Є14 billion.
The acquisition further advances AlTi's growth strategy to become the leading global independent wealth management platform for the UHNW, with targeted expertise in alternatives. This landmark transaction is the first European-based acquisition AlTi has executed following the strategic investment from Allianz X and Constellation Wealth Capital, having completed two US-based acquisitions in 2024. A portion of the funding from Allianz X was earmarked for AlTi's expansion into Germany, reflecting the opportunity within the German wealth management market.
Kontora is a founder-run business with a close-to 20-year track record, offering a range of services including family office, investment office, and service office solutions, tailored to preserve and grow client wealth across generations. Kontora, which primarily serves clients in Germany and Austria, specializes in open and closed-end funds and alternative strategies, with a service office focused on the administration and structuring of financial assets for large family offices, foundations, and non-profits. As part of the transaction, it is expected that Co-Chief Executive Officers Stephan Buchwald and Dr. Patrick Maurenbrecher will reinvest a portion of the proceeds into AlTi and will undertake senior positions within AlTi to play a key role in the execution of AlTi's strategy for the German market.

ALTI

AlTi Global Expands into Germany with Acquisition of Kontora, Adding €14B in AUM

David Kostin, the Chief U.S. Equity Strategist of Goldman Sachs, has revised his earnings growth forecast, citing a weaker economic outlook, and highlighted a shift in market trends.
What Happened: On CNBC&#8217;s &#8216;Squawk on the Street&#8217;, Kostin discussed his revised earnings growth forecast and market trends. Initially projected at 11%, the earnings growth forecast for 2025 has now been adjusted to 9%. 
Despite this, Kostin maintains that the earnings growth for 2026 remains at 7%, unchanged. He also stated that the S&amp;P 500 year-end target remains at 6500, suggesting an 11% gain from current levels.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Goldman Sachs&#039; Kostin: We&#039;re revising EPS growth forecast lower, but healthcare poses opportunity" width="500" height="281" src="https://www.youtube.com/embed/Pn9ySR9ygao?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Kostin also noted a shift in investment strategy, with investors moving from &#8220;excitement&#8221; (cyclicals) to &#8220;boredom&#8221;&nbsp;(defensive stocks) amid tariff&nbsp;uncertainties. He identified healthcare and consumer staples as preferred sectors for their stability and less sensitivity to the ongoing trade war. He also named&nbsp;Thermo Fisher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMO#NYSE">TMO</a>) and Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) as strong investment options. 
Furthermore, he notes a shift in focus from AI infrastructure and hyperscalers to software companies that would be leveraging AI to amplify their revenues, for instance, MongoDB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>). 
According to Kostin, uncertainty around tariffs makes forecasting difficult, but models suggest&nbsp;earnings will be impacted through unit volumes and margins. The strategist estimated that a 5% increase in tariffs&nbsp;could reduce earnings growth by&nbsp;1-2%.
SEE ALSO: <a href="https://www.benzinga.com/general/space/25/03/44102170/spacex-scraps-starship-flight-test-on-monday-too-many-question-marks-about-this-flight-says-ceo-elon-musk">SpaceX Scraps Starship Flight Test On Monday: &#8216;Too Many Question Marks About This Flight&#8230;,&#8217; Says CEO Elon Musk</a>
Why It Matters: This shift in investment strategy is noteworthy, considering that institutional investors were bullish on technology and financials during the fourth quarter of 2024. Investors were seen <a href="https://www.benzinga.com/markets/equities/25/02/43878703/institutional-investors-load-up-on-technology-and-financial-stocks-in-q4-while-reducing-positions-in-healthcare-sector-amid-political-uncertainty">pulling back</a> from the healthcare sector, which Kostin now identifies as a preferred sector. Even Warren Buffet&#8216;s Berkshire Hathaway trimmed its stake in healthcare provider DaVita Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVA#NYSE">DVA</a>), bringing down the ownership to 45%.
These market shifts and Kostin&#8217;s revised forecast underline the uncertainties in the current economic climate but also highlight potential&nbsp;opportunities in defensive sectors and&nbsp;AI-driven businesses. That being said, Kostin expects the falling bond yields to offset some tariff effects, potentially benefiting the economy. He summed up by saying that GDP growth is the primary driver of earnings, with interest rates and inflation playing secondary roles.
The S&amp;P 500 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) climbed 1.12% to close at 5,842.63 on Wednesday after President Donald Trump pushed back auto tariffs on Canada and Mexico by one month.
<ul>
<li>READ MORE: <a href="https://www.benzinga.com/markets/25/03/44159766/us-indicts-12-chinese-nationals-over-alleged-global-hacking-operation-targeting-critics-been-paying-hackers-for-hire-to-inflict-digital-harm-on-americans">US Indicts 12 Chinese Nationals Over Alleged Global Hacking Operation Targeting Critics: &#8216;&#8230;Been Paying Hackers-For-Hire To Inflict Digital Harm On Americans&#8217;</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

Markets

Goldman Sachs Cuts Earnings Growth Outlook, Sees Investors Move From 'Excitement' To 'Boredom'

RVLV

Revolve Group And Muus Collective, Inc. Announced The Worldwide Launch Of BELLEMINT, The Cutting-edge Fashion Styling Game That Seamlessly Merges Interactive Play With Real-world Shopping

Reported Earlier, Lockheed Martin's LM 400 Tech Demo To Prove Out Design And Risk Reduction Efforts On Orbit Ready To Launch No Earlier Than March 15

Reported Earlier, Dupont Will Showcase Its Cutting-edge Advancements In Circuit Materials At Intelligent Asia Thailand 2025

Reported Earlier, Lithium Americas Announced A Strategic Investment Of $250M From Fund Entities Managed By Orion Resource Partners LP

Fortuna Silver Mines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSM#NYSE">FSM</a>) reported quarterly earnings of $0.12 per share which missed the analyst consensus estimate of $0.18 by 33.33 percent. This is a 71.43 percent increase over earnings of $0.07 per share from the same period last year. The company reported quarterly sales of $302.20 million which beat the analyst consensus estimate of $262.78 million by 15.00 percent. This is a 13.90 percent increase over sales of $265.31 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

Reported Earlier,Fortuna Silver Mines Q4 2024 Adj EPS $0.12 Misses $0.18 Estimate, Sales $302.20M Beat $262.78M Estimate

CFLT

Confluent Announced Sccc By Stc—A Leading Cloud Services Provider In Saudi Arabia—Has Joined The Confluent OEM Program As A Managed Service Provider (MSP) To Make Data Streaming More Accessible In Saudi Arabia

ALGM

Reported Earlier, Onsemi Submitted Proposal To The Board Of Directors Of Allegro Microsystem To Acquire The Company For $35.10 Per Share In Cash At An Implied Enterprise Value Of $6.9B

Reported Earlier, The Allegro Board Of Directors Reviewed The Unsolicited Acquisition Proposal From Onsemi For $35.10 Per Share, In Consultation With Its Independent Financial And Legal Advisors, And Determined That The Proposal Was Inadequate

QGEN

QIAGEN Announced That The U.S. Food And Drug Administration (FDA) Has Cleared The QIAstat-Dx Gastrointestinal Panel 2 Mini B For Clinical Use, Further Strengthening Its Syndromic Testing Portfolio In The United States

Boeing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) CEO Kelly Ortberg expects forthcoming employee feedback to deliver a harsh reality check to the aerospace <a href="https://www.benzinga.com/25/02/43865891/elon-musks-involvement-key-to-solving-boeings-air-force-one-delivery-crisis-report">giant&#8217;s management team</a>.
What Happened: The CEO warned that the recent survey results will likely be &#8220;brutal to leadership,&#8221; according to a partial transcript of a company-wide meeting seen by Reuters.
The candid admission came during an all-hands webcast from St. Louis on Wednesday, where Ortberg outlined his diagnosis of the troubled manufacturer&#8217;s deep-seated cultural problems. The February survey, which garnered responses from an impressive 82% of Boeing&#8217;s workforce, forms a crucial part of Ortberg&#8217;s strategy to transform the company&#8217;s organizational dysfunction.
&#8220;We&#8217;re very insular&#8221; and &#8220;we don&#8217;t communicate across boundaries,&#8221; Ortberg told employees. &#8220;Teams don&#8217;t work with each other as well as we could, and the power of the Boeing Company is in us all kind of rowing the boat together.&#8221;
See Also:&nbsp;<a href="https://www.benzinga.com/personal-finance/25/03/44068159/nba-legend-shaq-says-his-net-worth-quadrupled-once-he-took-note-from-jeff-bezos-and-started-investing-in-things-that-change-peoples-lives" target="_blank" rel="noreferrer noopener">NBA Legend Shaq Says His Net Worth ‘Quadrupled&#8217; Once He Took Note From Jeff Bezos And Started Investing In Things That ‘Change People&#8217;s Lives&#8217;</a>
Why It Matters: This unflinching acknowledgment of leadership failures comes as Boeing <a href="https://www.benzinga.com/news/earnings/25/01/43179806/boeing-stock-falls-on-preliminary-q4-results-the-details">struggles to recover</a> from nearly $12 billion in losses during 2024 and persistent production issues with its 737 MAX, 787, and several defense programs, including the delayed Air Force One replacements.
Since taking the helm in August after Dave Calhoun&#8216;s departure, Ortberg has established a culture working group composed of employees from across the company to examine its values and behaviors. The CEO plans to use the survey results, however uncomfortable they might be for executives, to develop a comprehensive action plan.
Paradoxically, despite the company&#8217;s struggles and ongoing workforce reductions <a href="https://www.benzinga.com/25/02/43865891/elon-musks-involvement-key-to-solving-boeings-air-force-one-delivery-crisis-report">targeting about 10% of its 170,000 employees</a>, Ortberg expressed surprise at Boeing&#8217;s low attrition rate. &#8220;The fact that we don&#8217;t have huge attrition in the company, given what we&#8217;ve been through, is shocking,&#8221; he said. 
Read Next:
<ul>
<li><a href="https://www.benzinga.com/personal-finance/25/03/44065932/mark-cuban-was-asked-how-hed-invest-100k-his-answer-buy-bulk-toothpaste-and-soup-for-the-best-guaranteed-return-on-investment" target="_blank" rel="noreferrer noopener">Mark Cuban Was Asked How He&#8217;d Invest $100K — His Answer? Buy Bulk Toothpaste And Soup For The ‘Best Guaranteed Return On Investment&#8217;</a></li>
</ul>
Image Via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Boeing CEO Warns Of 'Brutal' Employee Survey Results, Kelly Ortberg Admits Deep Cultural Problems Amid Struggles To Recover From $12 Billion Loss

EDVMF

Endeavour Mining Q4 Adj. EPS $0.45 Vs $0.17 YoY, Revenue $941M Up From $579M YoY

EV giant Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) is offering free supercharging upon taking delivery of a new foundation series Cybertruck from its inventory in both Mexico and Canada, in a likely bid to make the expensive truck more appealing to customers.
What Happened: Tesla says on its website that the order must be placed on or after March 5 for the offer. The offer is valid till the customer&#8217;s ownership of the vehicle and cannot be transferred. 
Supercharger fees like idle and congestion fees will continue to be applicable, the company noted. 
The Cybertruck is one of Tesla&#8217;s most expensive offerings. In Mexico, the truck starts at around 1.95 million Mexican pesos while in Canada, it starts at C$114,990 for the base version.
The Cyberbeast variant of the truck is priced higher.
Why It Matters: Tesla is also offering discounts to entice Cybertruck buyers in the U.S. The company is now offering discounts up to $6000 on model year 2024 foundation series Cybertrucks and $4000 on non-foundation series Cybertrucks in its inventory.
Tesla CEO Elon Musk previously said that the company is eyeing a production rate of&nbsp;<a href="https://www.benzinga.com/24/12/42262279/a-year-after-teslas-first-cybertruck-deliveries-the-truck-has-a-long-way-to-go-to-meet-musks-goals" target="_blank" rel="noreferrer noopener">250,000 Cybertrucks a year</a>&nbsp;in 2025. However, this number is unlikely according to Tesla researcher Troy Teslike, who tracks the company&#8217;s production and delivery numbers, owing to poor demand. 
&#8220;The order backlog is gone. Tesla ended 2024 with 10,600 unsold Cybertrucks because of too much production and low demand,&#8221; the researcher said earlier in February while also dismissing the possibility of a cheaper Cybertruck variant launch this year.
&#8220;A cheaper Cybertruck this year is unlikely because the Cybertruck is not profitable. A cheaper version would make things worse,&#8221; he said.
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44101333/fords-mustang-mach-e-leads-companys-us-ev-sales-in-feb-but-trump-tariffs-threaten-future" target="_blank" rel="noreferrer noopener">Ford&#8217;s Mustang Mach-E Leads Company&#8217;s US EV Sales In Feb But Trump Tariffs Threaten Future</a></li>
</ul>
Photo courtesy: Shutterstock

Tech

TSLA

Tesla Offers Lifetime Free Supercharging On Foundation Series Cybertruck Purchases In Canada, Mexico

United Microelectronics Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UMC#NYSE">UMC</a>, TWSE: 2303))) ("UMC"), today reported unaudited net sales for the month of February 2025.
Revenues for February 2025
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">Period</td>
<td colspan="1" rowspan="1">2025</td>
<td colspan="1" rowspan="1">2024</td>
<td colspan="1" rowspan="1">Y/Y Change</td>
<td colspan="1" rowspan="1">Y/Y (%)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">February</td>
<td colspan="1" rowspan="1">18,193,515</td>
<td colspan="1" rowspan="1">17,451,268</td>
<td colspan="1" rowspan="1">742,247</td>
<td colspan="1" rowspan="1">4.25%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Jan.-Feb.</td>
<td colspan="1" rowspan="1">38,000,310</td>
<td colspan="1" rowspan="1">36,464,965</td>
<td colspan="1" rowspan="1">1,535,345</td>
<td colspan="1" rowspan="1">4.21%</td>
</tr>
</tbody>
</table>
</figure><figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">(&#x2A;) All figures in thousands of New Taiwan Dollars (NT$), except for percentages</td>
</tr>
</tbody>
</table>
</figure>

United Microelectronics Reported February Revenue Growth Of 4.25% YoY

<h3>Companies Reporting Before The Bell</h3>
• Priority Tech Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTH#NASDAQ">PRTH</a>) is expected to report quarterly earnings at $0.07 per share on revenue of $227.93 million. 
• KVH Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KVHI#NASDAQ">KVHI</a>) is projected to report quarterly loss at $0.07 per share on revenue of $28.12 million. 
• Dingdong (Cayman) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DDL#NYSE">DDL</a>) is projected to report quarterly earnings at $0.00 per share on revenue of $793.81 million. 
• Seanergy Maritime Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHIP#NASDAQ">SHIP</a>) is likely to report quarterly earnings at $0.43 per share on revenue of $40.15 million. 
• Dynagas LNG Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLNG#NYSE">DLNG</a>) is estimated to report quarterly earnings at $0.28 per share on revenue of $38.34 million. 
• ALX Oncology Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALXO#NASDAQ">ALXO</a>) is likely to report earnings for its fourth quarter. 
• Ranpak Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PACK#NYSE">PACK</a>) is expected to report quarterly loss at $0.02 per share on revenue of $100.41 million. 
• VerifyMe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRME#NASDAQ">VRME</a>) is likely to report quarterly loss at $0.04 per share on revenue of $8.21 million. 
• Xeris Biopharma Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XERS#NASDAQ">XERS</a>) is likely to report quarterly loss at $0.05 per share on revenue of $60.00 million. 
• Stevanato Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STVN#NYSE">STVN</a>) is projected to report quarterly earnings at $0.20 per share on revenue of $352.00 million. 
• Phathom Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHAT#NASDAQ">PHAT</a>) is projected to report quarterly loss at $1.07 per share on revenue of $26.04 million. 
• John Wiley &amp; Sons (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLYB#NYSE">WLYB</a>) is likely to report earnings for its third quarter. 
• John Wiley &amp; Sons (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLY#NYSE">WLY</a>) is projected to report quarterly earnings at $0.45 per share on revenue of $401.10 million. 
• Turning Point Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPB#NYSE">TPB</a>) is projected to report quarterly earnings at $0.75 per share on revenue of $102.27 million. 
• Macy's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/M#NYSE">M</a>) is estimated to report quarterly earnings at $1.91 per share on revenue of $7.84 billion. 
• Burlington Stores (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BURL#NYSE">BURL</a>) is likely to report quarterly earnings at $3.76 per share on revenue of $3.29 billion. 
• Kroger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KR#NYSE">KR</a>) is expected to report quarterly earnings at $1.09 per share on revenue of $34.87 billion. 
• Mind Medicine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNMD#NASDAQ">MNMD</a>) is projected to report earnings for its fourth quarter. 
• JD.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>) is estimated to report quarterly earnings at $0.80 per share on revenue of $45.16 billion. 
• Delcath Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DCTH#NASDAQ">DCTH</a>) is estimated to report quarterly loss at $0.02 per share on revenue of $12.42 million. 
• Cracker Barrel Old (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBRL#NASDAQ">CBRL</a>) is likely to report quarterly earnings at $0.41 per share on revenue of $836.96 million. 
• GMS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMS#NYSE">GMS</a>) is projected to report quarterly earnings at $1.40 per share on revenue of $1.29 billion. 
• Superior Industries Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUP#NYSE">SUP</a>) is expected to report quarterly loss at $0.60 per share on revenue of $300.28 million. 
• Evogene (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVGN#NASDAQ">EVGN</a>) is expected to report quarterly loss at $0.73 per share on revenue of $3.62 million. 
• Marex Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRX#NASDAQ">MRX</a>) is expected to report quarterly earnings at $0.61 per share on revenue of $370.82 million. 
• ProFrac Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACDC#NASDAQ">ACDC</a>) is likely to report quarterly loss at $0.23 per share on revenue of $498.50 million. 
• Toro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTC#NYSE">TTC</a>) is expected to report quarterly earnings at $0.63 per share on revenue of $1.01 billion. 
• Sunrise Realty Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SUNS#NASDAQ">SUNS</a>) is projected to report earnings for its fourth quarter. 
• Vanguard Extended Duration Treasury ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EDV#NYSE">EDV</a>) is projected to report earnings for its fourth quarter. 
• BrightSpring Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTSG#NASDAQ">BTSG</a>) is likely to report quarterly earnings at $0.20 per share on revenue of $2.95 billion. 
• America's Car-Mart (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRMT#NASDAQ">CRMT</a>) is expected to report quarterly earnings at $0.17 per share on revenue of $273.39 million. 
• BlackSky Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKSY#NYSE">BKSY</a>) is projected to report quarterly loss at $0.26 per share on revenue of $34.23 million. 
• Distribution Solns Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DSGR#NASDAQ">DSGR</a>) is likely to report quarterly earnings at $0.33 per share on revenue of $463.80 million. 
• Hippo Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIPO#NYSE">HIPO</a>) is projected to report quarterly earnings at $0.07 per share on revenue of $98.75 million. 
• Polestar Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSNY#NASDAQ">PSNY</a>) is expected to report quarterly loss at $0.15 per share on revenue of $634.04 million. 
• Canadian Natural Res (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNQ#NYSE">CNQ</a>) is likely to report quarterly earnings at $0.95 per share on revenue of $8.90 billion. 
• Real Brokerage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REAX#NASDAQ">REAX</a>) is likely to report quarterly loss at $0.05 per share on revenue of $282.20 million. 
• Myers Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MYE#NYSE">MYE</a>) is likely to report quarterly earnings at $0.10 per share on revenue of $203.10 million. 
• TORM (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRMD#NASDAQ">TRMD</a>) is expected to report quarterly earnings at $0.74 per share on revenue of $280.86 million. 
• BJ's Wholesale Club (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BJ#NYSE">BJ</a>) is expected to report quarterly earnings at $0.86 per share on revenue of $5.30 billion. 
<h3>Companies Reporting After The Bell</h3>
• Samsara (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IOT#NYSE">IOT</a>) is expected to report quarterly earnings at $0.07 per share on revenue of $335.35 million. 
• Lexicon Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LXRX#NASDAQ">LXRX</a>) is estimated to report quarterly loss at $0.12 per share on revenue of $6.48 million. 
• DXP Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXPE#NASDAQ">DXPE</a>) is estimated to report quarterly earnings at $0.86 per share on revenue of $431.00 million. 
• Reliance Global Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RELI#NASDAQ">RELI</a>) is projected to report earnings for its fourth quarter. 
• Cherry Hill Mortgage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHMI#NYSE">CHMI</a>) is expected to report quarterly earnings at $0.19 per share on revenue of $2.37 million. 
• Research Frontiers (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REFR#NASDAQ">REFR</a>) is expected to report earnings for its fourth quarter. 
• Silvercrest Asset Mgmt Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAMG#NASDAQ">SAMG</a>) is likely to report quarterly earnings at $0.30 per share on revenue of $31.97 million. 
• Xtant Medical Hldgs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/XTNT#AMEX">XTNT</a>) is projected to report quarterly loss at $0.02 per share on revenue of $31.80 million. 
• Cango (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CANG#NYSE">CANG</a>) is likely to report earnings for its fourth quarter. 
• ModivCare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MODV#NASDAQ">MODV</a>) is projected to report quarterly earnings at $0.69 per share on revenue of $717.27 million. 
• Comstock (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/LODE#AMEX">LODE</a>) is projected to report quarterly loss at $0.20 per share on revenue of $700 thousand. 
• Marchex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHX#NASDAQ">MCHX</a>) is likely to report quarterly loss at $0.02 per share on revenue of $12.01 million. 
• GEN Restaurant Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GENK#NASDAQ">GENK</a>) is likely to report quarterly loss at $0.03 per share on revenue of $49.77 million. 
• CytomX Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTMX#NASDAQ">CTMX</a>) is estimated to report quarterly loss at $0.13 per share on revenue of $13.53 million. 
• Atea Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVIR#NASDAQ">AVIR</a>) is estimated to report earnings for its fourth quarter. 
• National CineMedia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCMI#NASDAQ">NCMI</a>) is projected to report quarterly earnings at $0.31 per share on revenue of $83.72 million. 
• Fidus Investment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FDUS#NASDAQ">FDUS</a>) is estimated to report quarterly earnings at $0.52 per share on revenue of $36.66 million. 
• Molecular Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOLN#NASDAQ">MOLN</a>) is estimated to report quarterly loss at $1.61 per share on revenue of $5.00 million. 
• IDT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IDT#NYSE">IDT</a>) is expected to report earnings for its second quarter. 
• Smith &amp; Wesson Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWBI#NASDAQ">SWBI</a>) is likely to report quarterly earnings at $0.02 per share on revenue of $119.46 million. 
• Arcturus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARCT#NASDAQ">ARCT</a>) is estimated to report quarterly loss at $0.51 per share on revenue of $45.92 million. 
• Serve Robotics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERV#NASDAQ">SERV</a>) is expected to report quarterly loss at $0.13 per share on revenue of $254 thousand. 
• Clarus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLAR#NASDAQ">CLAR</a>) is expected to report quarterly earnings at $0.09 per share on revenue of $69.03 million. 
• Guidewire Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWRE#NYSE">GWRE</a>) is expected to report quarterly earnings at $0.52 per share on revenue of $285.83 million. 
• Elutia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELUT#NASDAQ">ELUT</a>) is likely to report quarterly loss at $0.25 per share on revenue of $6.40 million. 
• MeridianLink (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLNK#NYSE">MLNK</a>) is projected to report quarterly earnings at $0.08 per share on revenue of $78.53 million. 
• Asure Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASUR#NASDAQ">ASUR</a>) is estimated to report quarterly earnings at $0.17 per share on revenue of $30.82 million. 
• BigBear.ai Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBAI#NYSE">BBAI</a>) is projected to report quarterly loss at $0.05 per share on revenue of $54.17 million. 
• Traeger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COOK#NYSE">COOK</a>) is projected to report quarterly earnings at $0.01 per share on revenue of $164.62 million. 
• Domo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOMO#NASDAQ">DOMO</a>) is projected to report quarterly loss at $0.16 per share on revenue of $78.00 million. 
• AerSale (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASLE#NASDAQ">ASLE</a>) is estimated to report quarterly earnings at $0.08 per share on revenue of $91.78 million. 
• Guild Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GHLD#NYSE">GHLD</a>) is projected to report quarterly earnings at $0.37 per share on revenue of $272.74 million. 
• Hudson Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HDSN#NASDAQ">HDSN</a>) is expected to report quarterly loss at $0.02 per share on revenue of $37.96 million. 
• a.k.a. Brands Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AKA#NYSE">AKA</a>) is projected to report quarterly loss at $0.23 per share on revenue of $154.49 million. 
• American Outdoor Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AOUT#NASDAQ">AOUT</a>) is likely to report quarterly earnings at $0.10 per share on revenue of $56.78 million. 
• Funko (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FNKO#NASDAQ">FNKO</a>) is likely to report quarterly earnings at $0.00 per share on revenue of $285.79 million. 
• Gevo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEVO#NASDAQ">GEVO</a>) is likely to report quarterly loss at $0.07 per share on revenue of $3.95 million. 
• American Public Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APEI#NASDAQ">APEI</a>) is estimated to report quarterly earnings at $0.62 per share on revenue of $161.78 million. 
• El Pollo Loco Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOCO#NASDAQ">LOCO</a>) is projected to report quarterly earnings at $0.14 per share on revenue of $115.83 million. 
• Noodles (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDLS#NASDAQ">NDLS</a>) is likely to report quarterly loss at $0.14 per share on revenue of $121.36 million. 
• Potbelly (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBPB#NASDAQ">PBPB</a>) is projected to report quarterly earnings at $0.05 per share on revenue of $115.23 million. 
• Loma Negra Cia Industria (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LOMA#NYSE">LOMA</a>) is estimated to report quarterly loss at $0.10 per share on revenue of $221.13 million. 
• Granite Ridge Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GRNT#NYSE">GRNT</a>) is expected to report quarterly earnings at $0.13 per share on revenue of $104.93 million. 
• Invesco Dorsey Wright Industrials Momentum ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRN#NASDAQ">PRN</a>) is likely to report quarterly loss at $0.47 per share on revenue of $5.92 million. 
• Profound Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PROF#NASDAQ">PROF</a>) is expected to report quarterly loss at $0.34 per share on revenue of $5.92 million. 
• Gap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GAP#NYSE">GAP</a>) is projected to report quarterly earnings at $0.38 per share on revenue of $4.07 billion. 
• Hewlett Packard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPE#NYSE">HPE</a>) is projected to report quarterly earnings at $0.50 per share on revenue of $7.82 billion. 
• HASHICORP INC CL A (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCP#NASDAQ">HCP</a>) is projected to report quarterly earnings at $0.08 per share on revenue of $175.71 million. 
• ACCESS Newswire (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ACCS#AMEX">ACCS</a>) is likely to report quarterly earnings at $0.23 per share on revenue of $7.38 million. 
• Information Servs Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/III#NASDAQ">III</a>) is expected to report quarterly earnings at $0.05 per share on revenue of $57.62 million. 
• Full House Resorts (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLL#NASDAQ">FLL</a>) is likely to report quarterly loss at $0.19 per share on revenue of $75.78 million. 
• Willdan Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WLDN#NASDAQ">WLDN</a>) is expected to report quarterly earnings at $0.57 per share on revenue of $145.00 million. 
• Broadcom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) is expected to report quarterly earnings at $1.47 per share on revenue of $14.62 billion. 
• Ero Copper (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ERO#NYSE">ERO</a>) is estimated to report earnings for its fourth quarter. 
• Velocity Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEL#NYSE">VEL</a>) is estimated to report quarterly earnings at $0.48 per share on revenue of $42.70 million. 
• Cooper Companies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COO#NASDAQ">COO</a>) is expected to report quarterly earnings at $0.92 per share on revenue of $980.87 million. 
• Costco Wholesale (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>) is expected to report quarterly earnings at $4.01 per share on revenue of $62.61 billion. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ACCS

ACDC

ALXO

AOUT

APEI

ARCT

ASLE

ASUR

AVGO

AVIR

BBAI

BlackSky Technology Inc. Class A Common Stock

BKSY

BTSG

BURL

CANG

CBRL

CHMI

CLAR

COOK

COST

CRMT

CTMX

DCTH

DLNG

DOMO

DSGR

DXPE

ELUT

EVGN

FDUS

FNKO

GENK

GEVO

GHLD

GRNT

GWRE

HDSN

HIPO

KVHI

LOCO

LODE

LOMA

LXRX

MCHX

MLNK

MNMD

MODV

MOLN

NCMI

NDLS

PACK

PBPB

PHAT

PowerShares Dynamic Industrials Sector Portfolio

PROF

PRTH

PSNY

REAX

REFR

RELI

SAMG

SERV

SHIP

STVN

SUNS

SWBI

TRMD

VRME

WLDN

WLYB

XERS

XTNT

Earnings Scheduled For March 6, 2025

Marvell Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) smashed its artificial intelligence data center revenue target in fiscal 2025. The chipmaker also reiterated plans to exceed fiscal 2026&#8217;s target but issued a soft earnings and revenue guidance which was roughly in-line with analyst estimates.
What Happened: About 75% of Marvell&#8217;s total revenue in the fourth quarter was driven by AI data center-led sales. Whereas for the full fiscal year 2025, the company&#8217;s AI revenue was substantially above its $1.5 billion target.
&#8220;We also expect to very significantly exceed our $2.5 billion target in fiscal 2026,&#8221; said Matthew Murphy, the chairman, president, and CEO of the company.
While the CFO Willem Meintjes issued a revenue guidance in the range of $1.875 billion, with a plus or minus 5% possibility, it was roughly in-line with the street&#8217;s $1.87 billion expectation. Shares of the company plunged nearly 15% in after-hours trading based on the soft guidance.
&#8220;We project our overall revenue from the auto and industrial end market to decline sequentially in the high single digits on a percentage basis,&#8221; added the CEO.
The management also emphasized the &#8220;stickiness&#8221; of its custom silicon wins due to its technology leadership, manufacturing scale, and close customer relationships.
See Also: <a href="https://www.benzinga.com/general/market-summary/25/03/44159401/rigetti-claims-leadership-in-quantum-computing-race-aims-to-scale-to-100-qubits-as-it-looks-to-catch-up-with-ibm-google">Rigetti Asserts &#8216;Leadership&#8217; In Quantum Computing Race, Aims To Scale To 100 Qubits As It Looks To Catch Up With IBM, Google</a>
Why It Matters: The company beat its fourth quarter estimates with adjusted EPS of $0.60 and revenue of $1.81 billion. It generated $514 million in operating cash flow and a 60.1% non-GAAP gross margin.
The shares ended 2.05% higher on Wednesday but slipped 14.85% in after-hours. The exchange-traded fund tracking Nasdaq 100 index, Invesco QQQ Trust, Series 1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) ended 1.30% higher on Wednesday and fell 0.32% in after-hours.
On a year-to-date basis MRVL has fallen by 20.62% but it&#8217;s up 10.78% over the last year.
Analyst Recommendations:<a href="https://www.benzinga.com/quote/MRVL/analyst-ratings"> Benzinga tracks 33 analysts</a> with an average price target of $113.69 for the stock, reflecting a &#8220;buy&#8221; rating. Estimates range widely from $75 to $150. Recent ratings from Morgan Stanley, Keybanc, and Barclays average at $132.67, suggesting a potential 72.86% upside.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/MRVL/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="383" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/06025350/MRVL-ANR-1024x383.png" alt="" class="wp-image-811605" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/06025350/MRVL-ANR-1024x383.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/06025350/MRVL-ANR-300x112.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/06025350/MRVL-ANR-768x287.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/06025350/MRVL-ANR.png 1068w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/25/03/44135177/trump-seeks-to-end-chips-act-who-stands-to-lose-heres-a-list-of-beneficiaries-that-could-be-affected" target="_blank" rel="noreferrer noopener">Trump Seeks To End CHIPS Act: Who Stands To Lose? Here&#8217;s A List Of Beneficiaries That Could Be Affected</a></li>
</ul>
Photo courtesy: Shutterstock

Market Summary

Analyst Ratings

MRVL

Marvell Surpasses AI Chip Sales Target, Aims Higher For 2026, But Stock Plunges Due To Muted Guidance

On Wednesday, Apple Inc. co-founder Steve Wozniak criticized the Department of Government Efficiency's or DOGE <a href="https://in.benzinga.com/25/02/43754316/irs-gears-up-to-lay-off-thousands-of-workers-potentially-impacting-tax-season-no-analysis-to-the-impact-it-will-have-on-operations">approach to mass layoffs</a>, calling its sweeping federal workforce cuts a reckless strategy that lacks precision.
What Happened: During an interview <a href="https://www.cnbc.com/2025/03/05/apple-co-founder-steve-wozniak-donald-trump-and-elon-musk-are-bullies.html">with</a> CNBC, Wozniak expressed concerns over DOGE's aggressive cost-cutting tactics, which have resulted in thousands of federal employees losing their jobs.
&#8220;Mass firings — not good for a business to run that way,&#8221; he stated, suggesting that instead of indiscriminate cuts, DOGE should approach workforce reductions "more surgically, with a scalpel instead of a sledgehammer."
See Also: <a href="https://www.benzinga.com/25/03/44158377/elon-musks-influence-under-scrutiny-as-senate-votes-to-block-cfpbs-oversight-of-digital-payments-sparks-ethics-investigation">Elon Musk&#8217;s Influence Under Scrutiny As Senate Votes To Block CFPB&#8217;s Digital Payments Oversight, Sparks Conflict-Of Interest Probe</a>
The Apple co-founder has previously also criticized Tesla Inc. and found himself at odds with Elon Musk.
While the White House maintains that Musk does <a href="https://in.benzinga.com/25/02/43801916/elon-musk-has-no-actual-authority-to-make-government-decisions-says-trump-white-house-on-doge">not officially lead DOGE</a>, President Donald Trump mentioned <a href="https://www.benzinga.com/markets/equities/25/03/44133368/trumps-congressional-address-taps-elon-musk-for-government-overhaul-revives-drill-baby-drill-for-energy-boom">during his address on Tuesday</a> that "DOGE is headed by Elon Musk," reinforcing the widespread belief that he is the driving force behind the agency.
DOGE's mass layoffs have sparked controversy. The agency's actions have also <a href="https://in.benzinga.com/news/25/02/43578729/court-halts-musks-doge-squad-from-gaining-access-to-treasury-payment-systems-a-risk-of-irreparable-harm">prompted legal challenges</a>, with Trump's latest comments being flagged in an ongoing lawsuit against DOGE.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It Matters: Wozniak is not the only prominent business figure speaking out against DOGE. Billionaire entrepreneur Mark Cuban has also taken to Bluesky and said that the agency's cuts will "inevitably" create chaos, calling its approach "not so brilliant."
On the other hand, Jamie Dimon, CEO of JPMorgan Chase, has <a href="https://in.benzinga.com/news/25/03/44067853/jpmorgan-ceo-jamie-dimon-talks-doge-efficiency-and-trumps-regulatory-changes-weve-become-a-bureaucratic-mess">expressed support</a> for the idea of cutting wasteful spending but has also highlighted the chaos and legal challenges that DOGE&#8217;s methods have introduced.
DOGE is also said to have saved $65 billion. However, experts have labeled these statements as &#8220;<a href="https://in.benzinga.com/news/25/03/44143475/trumps-u-s-doge-service-claims-65b-in-savings-experts-call-it-smoke-and-mirrors-amid-resignations">smoke and mirrors</a>&#8221; amid a wave of resignations.
Check out more of Benzinga&#8217;s Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://in.benzinga.com/personal-finance/25/02/43752458/russell-vought-orders-pause-on-all-cfpb-activity-critics-say-this-gives-corporations-the-green-light-to-scam-families" target="_blank" rel="noreferrer noopener">Russell Vought Orders Pause On All CFPB Activity, Critics Say This Gives Corporations ‘The Green Light To Scam Families'</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Media

Apple Co-Founder Steve Wozniak Blasts DOGE's Mass Firings, Says Musk-Led Cuts Are Like Using A Sledgehammer Instead Of A Scalpel

Press Releases

Spotlight on Undervalued Nasdaq Stocks: HCWB, CRDL, NIVF, SINT, APLM – A Must-Watch This Week!

Cardiol Therapeutics (Nasdaq: CRDL) Advances Orphan Drug Designation for CardiolRx™ at the American Heart Association…more stocks inside…

"Game-Changers to Watch CRDL, RMSG, WORX, PET and more…Innovative Companies inside"

Thanksgiving Week Oversold Stocks to Watch: CRDL, QBTS, PRSO, RGTI & More!

"Market Movers: CTOR, CTNT, PNPN.V, KITT, SHIM – More Stocks Inside to Watch"

"Cardiol Therapeutics (NASDAQ: CRDL) Heart Health Innovation – AVCO, GXAI, UPC, and More Stocks Driving Groundbreaking Advances"

PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx™ Addressing Patients with Recurrent Pericarditis

Cardiol Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference

Cardiol Therapeutics Announces Publication of Research in the Journal of the American College of Cardiology: Basic to Translational Science That Supports Development of Its Proprietary Subcutaneous Drug Candidate, CRD-38, for the Treatment of Heart Failure

Comments

Cardiol Therapeutics

Noticias

Últimas noticias sobre Cardiol Therapeutics (NASDAQ:CRDL) Bolsa

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL